CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

ROTARIX

RegulatoryapprovedRotarixPositive
AI Analysis

Summary

Rotarix received FDA approval for prevention of rotavirus gastroenteritis caused by G1 and non-G1 types in infants aged 6 to 24 weeks.

Outcome Details

Rotarix approval indicated for prevention of rotavirus gastroenteritis in infants

Importance:5/10
Sentiment:
0.70
FDA approvalvaccinerotaviruspediatric
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on September 28, 2026 9:20 PM

Read Original